IHS Chemical Week

Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals

Haupt Pharma Merger Creates Major CMO Player in Europe

9:24 AM MDT | September 22, 2008 | Deepti Ramesh

The merger of three German contract manufacturers and developers earlier this month to form Haupt Pharma (Berlin) has created a major contract manufacturing organization (CMO) in Europe with eight production facilities, 1,500 employees, and sales of €180 million ($256 million). Invita (Plettenberg, Germany), an investment firm focused on the pharma market, owns the new company, which comprises Amareg (Regensburg), Haupt Pharma (Berlin), and Wülfing Pharma (Gronau). Amareg is mainly focused on cytostatics in film-coated tablet and capsule form as well as...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa